Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
AIDS Research and Human Retroviruses|March 10, 2000
Increased levels of soluble Fas receptor and Fas ligand in the cerebrospinal fluid of HIV-infected patientsB Sporer, U Koedel, F D Goebel, et al.Journal of Neuroimmunology|May 12, 2005
Evaluation of cerebrospinal fluid uPA, PAI-1, and soluble uPAR levels in HIV-infected patientsB Sporer, U Koedel, B Popp, et al.The Journal of Infectious Diseases|October 7, 2000
Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental Pneumococcal meningitisU Koedel, I Bayerlein, R Paul, et al.The Journal of Infectious Diseases|October 1, 1993
Imaging of leukocyte-endothelium interaction using in vivo confocal laser scanning microscopy during the early phase of experimental pneumococcal meningitisS Lorenzl, U Koedel, U Dirnagl, et al.European Journal of Neurology|February 11, 2014
Neuroinfectious diseases at a European neurological tertiary care center: one-third of patients require treatment in the neurological intensive care unitG Buchholz, S Ormanns, H-W Pfister, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1996
Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitisU Koedel, A Bernatowicz, K Frei, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 15, 1998
Endothelin B receptor-mediated increase of cerebral blood flow in experimental pneumococcal meningitisU Koedel, S Lorenzl, C Gorriz, et al.Journal of Neuroimmunology|April 20, 2001
Failure of alpha-melanocyte stimulating hormone to attenuate cerebral complications in experimental pneumococcal meningitisS Kastenbauer, U Koedel, T Brzoska, et al.Der Nervenarzt|November 26, 2005
[Cytokine CXCL13--a possible early CSF marker for neuroborreliosis]T A Rupprecht, U Koedel, B Angele, et al.The Journal of Experimental Medicine|July 1, 1992
Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitisH W Pfister, K Frei, B Ottnad, et al.Pageof 6